U. Darsow, A. Wollenberg, D. Simon, A. Taïeb, T. Werfel et al., ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis, Journal of the European Academy of Dermatology and Venereology, vol.142, issue.Suppl., pp.317-345, 2010.
DOI : 10.1111/j.1468-3083.2009.03415.x

C. Palmer, A. Irvine, A. Terron-kwiatkowski, Y. Zhao, H. Liao et al., Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis, Nature Genetics, vol.48, issue.4, pp.441-447, 2006.
DOI : 10.1038/ng1767

J. Schmitt, M. Romanos, A. Pfennig, K. Leopold, and M. Meurer, Psychiatric comorbidity in adult eczema, British Journal of Dermatology, vol.15, issue.Suppl., pp.878-83, 2009.
DOI : 10.1111/j.1365-2133.2009.09309.x

A. Taïeb, F. Boralevi, J. Seneschal, S. Merhand, V. Georgescu et al., Atopic Dermatitis Burden Scale for Adults: Development and Validation of a New Assessment Tool, Acta Dermato Venereologica, vol.95, issue.6, 2014.
DOI : 10.2340/00015555-1945

M. Schram, E. Roekevisch, M. Leeflang, J. Bos, J. Schmitt et al., A randomized trial of methotrexate versus azathioprine for severe atopic eczema, Journal of Allergy and Clinical Immunology, vol.128, issue.2, pp.353-362, 2011.
DOI : 10.1016/j.jaci.2011.03.024

F. Garritsen, E. Roekevisch, J. Van-der-schaft, J. Deinum, P. Spuls et al., Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres, Journal of the European Academy of Dermatology and Venereology, vol.169, issue.10, 2009.
DOI : 10.1111/jdv.13064

J. Hanifin and G. Rajka, Diagnostic features of atopic dermatitis, ActaDerm VenereolStockh), vol.92, pp.44-51, 1980.

V. Pascoe, M. Enamandram, K. Corey, C. Cheng, E. Javorsky et al., Using the Physician Global Assessment in a Clinical Setting to Measure and Track Patient Outcomes, JAMA Dermatology, vol.151, issue.4, 2014.
DOI : 10.1001/jamadermatol.2014.3513

J. Oldhoff, U. Darsow, T. Werfel, K. Katzer, A. Wulf et al., Anti-IL-5 recombinant humanized monoclonal antibody (Mepolizumab) for the treatment of atopic dermatitis, Allergy, vol.159, issue.5, pp.693-699, 2005.
DOI : 10.1164/rccm.2304001

M. Salek, A. Finlay, D. Luscombe, B. Allen, J. Berth-jones et al., Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial, British Journal of Dermatology, vol.19, issue.4, pp.422-452, 1993.
DOI : 10.1111/j.1365-2230.1987.tb01844.x

T. Van-joost, F. Heule, M. Korstanje, M. Van-den-broek, H. Stenveld et al., Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study, British Journal of Dermatology, vol.129, issue.5, pp.634-674, 1994.
DOI : 10.1016/S0140-6736(89)92941-3

J. Berth-jones, A. Takwale, E. Tan, G. Barclay, S. Agarwal et al., Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial, British Journal of Dermatology, vol.88, issue.2, pp.324-354, 2002.
DOI : 10.1001/archderm.131.2.193

S. Meggitt, J. Gray, and N. Reynolds, Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial, The Lancet, vol.367, issue.9513, pp.839-885, 2006.
DOI : 10.1016/S0140-6736(06)68340-2

S. Weatherhead, S. Wahie, N. Reynolds, and S. Meggitt, An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema, British Journal of Dermatology, vol.16, issue.2, 2007.
DOI : 10.1111/j.1365-2133.2005.06592.x

A. Lyakhovitsky, A. Barzilai, R. Heyman, S. Baum, B. Amichai et al., Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults, Journal of the European Academy of Dermatology and Venereology, vol.120, issue.6, pp.43-52, 2010.
DOI : 10.1111/j.1468-3083.2009.03351.x

M. El-khalawany, H. Hassan, D. Shaaban, N. Ghonaim, and B. Eassa, Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt, European Journal of Pediatrics, vol.135, issue.3, pp.351-357, 2013.
DOI : 10.1007/s00431-012-1893-3

T. Rath and A. Rubbert, Drug combinations with methotrexate to treat rheumatoid arthritis, Clin Exp Rheumatol, vol.28, issue.5, pp.52-59, 2010.

J. Schmitt, K. Schäkel, R. Fölster-holst, A. Bauer, R. Oertel et al., Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicentre trial, British Journal of Dermatology, vol.143, issue.Suppl. 62, pp.661-669, 2010.
DOI : 10.1111/j.1365-2133.2009.09561.x

I. Haeck, M. Knol, O. Berge, . Ten, S. Van-velsen et al., Enteric-coated mycophenolate sodium versus cyclosporin A??as long-term treatment in adult patients with severe atopic dermatitis: A??randomized controlled trial, Journal of the American Academy of Dermatology, vol.64, issue.6, pp.1074-84, 2011.
DOI : 10.1016/j.jaad.2010.04.027

A. Wollenberg, C. Zoch, S. Wetzel, G. Plewig, and B. Przybilla, Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases, Journal of the American Academy of Dermatology, vol.49, issue.2, pp.198-205, 2003.
DOI : 10.1067/S0190-9622(03)00896-X

A. Taïeb, J. Seneschal, and M. Mossalayi, Biologics in atopic dermatitis, JDDG: Journal der Deutschen Dermatologischen Gesellschaft, vol.64, issue.7, pp.174-182, 2012.
DOI : 10.1111/j.1610-0387.2011.07760.x

U. Darsow, A. Wollenberg, D. Simon, A. Taïeb, T. Werfel et al., ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis, Journal of the European Academy of Dermatology and Venereology, vol.142, issue.Suppl., pp.317-345, 2010.
DOI : 10.1111/j.1468-3083.2009.03415.x

J. Hanifin and G. Rajka, Diagnostic features of atopic dermatitis, ActaDerm VenereolStockh), vol.92, pp.44-51, 1980.

H. Williams, P. Burney, R. Hay, C. Archer, M. Shipley et al., The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis.., British Journal of Dermatology, vol.131, issue.3, pp.383-96, 1994.
DOI : 10.1016/0895-4356(90)90122-6

URL : https://hal.archives-ouvertes.fr/in2p3-00008652

J. Schmitt, M. Romanos, A. Pfennig, K. Leopold, and M. Meurer, Psychiatric comorbidity in adult eczema, British Journal of Dermatology, vol.15, issue.Suppl., pp.878-83, 2009.
DOI : 10.1111/j.1365-2133.2009.09309.x

J. Gong, L. Lin, T. Lin, F. Hao, F. Zeng et al., Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial, British Journal of Dermatology, vol.61, issue.4, pp.680-687, 2006.
DOI : 10.1111/j.1365-2133.1974.tb06447.x

W. Peng and N. Novak, Pathogenesis of atopic dermatitis, Clinical & Experimental Allergy, vol.192, issue.3, pp.566-74
DOI : 10.1111/all.12526

C. Bussmann, S. Weidinger, and N. Novak, Genetics of atopic dermatitis, JDDG: Journal der Deutschen Dermatologischen Gesellschaft, vol.162, issue.1 Pt 1, pp.670-676, 2011.
DOI : 10.1111/j.1610-0387.2011.07656.x

K. Eyerich and N. Novak, Immunology of atopic eczema: overcoming the Th1/Th2 paradigm, Allergy, vol.56, issue.2 Pt 1, pp.974-82, 2013.
DOI : 10.1111/all.12184

S. Weidinger, N. Klopp, L. Rümmler, S. Wagenpfeil, H. Baurecht et al., Association of CARD15 polymorphisms with atopy-related traits in a population-based cohort of Caucasian adults, Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, vol.9, issue.7, pp.866-72, 2005.
DOI : 10.1016/S1074-7613(01)00176-5

P. Ahmad-nejad, S. Mrabet-dahbi, K. Breuer, M. Klotz, T. Werfel et al., The Toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype, Journal of Allergy and Clinical Immunology, vol.113, issue.3, pp.565-572, 2004.
DOI : 10.1016/j.jaci.2003.12.583

N. Novak, C. Yu, C. Bussmann, L. Maintz, W. Peng et al., Putative association of a TLR9 promoter polymorphism with atopic eczema, Allergy, vol.7, issue.2 Suppl., pp.766-72, 2007.
DOI : 10.1111/j.1398-9995.2007.01358.x

N. Novak, S. Kruse, S. Kraft, E. Geiger, H. Klüken et al., Dichotomic Nature of Atopic Dermatitis Reflected by Combined Analysis of Monocyte Immunophenotyping and Single Nucleotide Polymorphisms of the Interleukin-4/Interleukin-13 Receptor Gene: The Dichotomy of Extrinsic and Intrinsic Atopic Dermatitis, Journal of Investigative Dermatology, vol.119, issue.4, pp.870-875, 2002.
DOI : 10.1046/j.1523-1747.2002.00191.x

J. He, M. Chan-yeung, A. Becker, H. Dimich-ward, A. Ferguson et al., Genetic variants of the IL13 and IL4 genes and atopic diseases in at-risk children, Genes and Immunity, vol.4, issue.5, 2003.
DOI : 10.1038/sj.gene.6363985

S. Weidinger, N. Klopp, S. Wagenpfeil, L. Rümmler, M. Schedel et al., Association of a STAT 6 haplotype with elevated serum IgE levels in a population based cohort of white adults, Journal of Medical Genetics, vol.41, issue.9, pp.658-63, 2004.
DOI : 10.1136/jmg.2004.020263

S. Weidinger, C. Gieger, E. Rodriguez, H. Baurecht, M. Mempel et al., Genome-Wide Scan on Total Serum IgE Levels Identifies FCER1A as Novel Susceptibility Locus, PLoS Genetics, vol.30, issue.8, 2008.
DOI : 10.1371/journal.pgen.1000166.s014

M. Kennedy, J. Loehle, A. Griffin, M. Doll, G. Kearns et al., -Methyltransferase C314T (Thr105Ile) Polymorphism with Atopic Dermatitis in Caucasian Children, Pharmacotherapy, vol.68, issue.12, pp.1495-501, 2008.
DOI : 10.1186/1471-2350-9-15

URL : https://hal.archives-ouvertes.fr/inserm-00409448

B. Yu, Y. Shao, J. Zhang, X. Dong, W. Liu et al., Polymorphisms in human histamine receptor H4 gene are associated with atopic dermatitis, British Journal of Dermatology, vol.6, issue.Suppl, pp.1038-1081, 2010.
DOI : 10.1111/j.1365-2133.2010.09675.x

A. Otsuka and K. Kabashima, Mast cells and basophils in cutaneous immune responses, Allergy, vol.192, issue.34 Suppl, pp.131-171, 2015.
DOI : 10.1111/all.12526

Y. Nakamura, J. Oscherwitz, K. Cease, S. Chan, R. Muñoz-planillo et al., Staphylococcus ??-toxin induces allergic skin disease by activating mast cells, Nature, vol.76, issue.7476, pp.397-401, 2013.
DOI : 10.1038/nature12655

Y. Liu, V. Soumelis, N. Watanabe, T. Ito, Y. Wang et al., TSLP: An Epithelial Cell Cytokine that Regulates T Cell Differentiation by Conditioning Dendritic Cell Maturation, Annual Review of Immunology, vol.25, issue.1, pp.193-219, 2007.
DOI : 10.1146/annurev.immunol.25.022106.141718

R. Saluja, A. Zoltowska, M. Ketelaar, and G. Nilsson, IL-33 and Thymic Stromal Lymphopoietin in mast cell functions, European Journal of Pharmacology, vol.778, 2015.
DOI : 10.1016/j.ejphar.2015.04.047

N. Novak, An update on the role of human dendritic cells in patients with atopic dermatitis, Journal of Allergy and Clinical Immunology, vol.129, issue.4, pp.879-86
DOI : 10.1016/j.jaci.2012.01.062

T. Tang, T. Bieber, and H. Williams, Does ???autoreactivity??? play a role in atopic dermatitis?, Journal of Allergy and Clinical Immunology, vol.129, issue.5, pp.1209-1224
DOI : 10.1016/j.jaci.2012.02.002

L. Beck, D. Thaçi, J. Hamilton, N. Graham, T. Bieber et al., Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis, New England Journal of Medicine, vol.371, issue.2, pp.130-139, 2014.
DOI : 10.1056/NEJMoa1314768

D. Malajian and E. Guttman-yassky, New pathogenic and therapeutic paradigms in atopic dermatitis, Cytokine, vol.73, issue.2, pp.311-319
DOI : 10.1016/j.cyto.2014.11.023

S. Hoffjan and S. Stemmler, Unravelling the complex genetic background of atopic dermatitis: from genetic association results towards novel therapeutic strategies, Archives of Dermatological Research, vol.27, issue.3
DOI : 10.1007/s00403-015-1550-6

C. Palmer, A. Irvine, A. Terron-kwiatkowski, Y. Zhao, H. Liao et al., Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis, Nature Genetics, vol.48, issue.4, pp.441-447, 2006.
DOI : 10.1038/ng1767

S. Weidinger, T. Illig, H. Baurecht, A. Irvine, E. Rodriguez et al., Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations, Journal of Allergy and Clinical Immunology, vol.118, issue.1, pp.214-223, 2006.
DOI : 10.1016/j.jaci.2006.05.004

R. Van-den-oord and A. Sheikh, Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis, BMJ, vol.339, issue.jul08 4, p.2433, 2009.
DOI : 10.1136/bmj.b2433

J. Henderson, K. Northstone, S. Lee, H. Liao, Y. Zhao et al., The burden of disease associated with filaggrin mutations: A population-based, longitudinal birth cohort study, Journal of Allergy and Clinical Immunology, vol.121, issue.4, pp.872-879, 2008.
DOI : 10.1016/j.jaci.2008.01.026

J. Thyssen and S. Kezic, Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis, Journal of Allergy and Clinical Immunology, vol.134, issue.4, pp.792-801, 2014.
DOI : 10.1016/j.jaci.2014.06.014

D. Benedetto, A. Rafaels, N. Mcgirt, L. Ivanov, A. Georas et al., Tight junction defects in patients with atopic dermatitis, Journal of Allergy and Clinical Immunology, vol.127, issue.3, pp.773-86, 2011.
DOI : 10.1016/j.jaci.2010.10.018

Y. Nishio, E. Noguchi, M. Shibasaki, M. Kamioka, E. Ichikawa et al., Association between polymorphisms in the SPINK5 gene and atopic dermatitis in the Japanese, Genes and Immunity, vol.4, issue.7, 2003.
DOI : 10.1038/sj.gene.6363889

L. Paternoster, M. Standl, C. Chen, A. Ramasamy, K. Bønnelykke et al., Meta-analysis of genome-wide association studies identifies three new risk loci for atopic dermatitis, Nature Genetics, vol.447, issue.2, pp.187-92, 2012.
DOI : 10.1086/519795

C. Söderhäll, I. Marenholz, T. Kerscher, F. Rüschendorf, J. Esparza-gordillo et al., Variants in a Novel Epidermal Collagen Gene (COL29A1) Are Associated with Atopic Dermatitis, PLoS Biology, vol.300, issue.9, p.242, 2007.
DOI : 10.1371/journal.pbio.0050242.st005

S. Stemmler, Q. Parwez, E. Petrasch-parwez, J. Epplen, and S. Hoffjan, Association of variation in the LAMA3 gene, encoding the alpha-chain of laminin 5, with atopic dermatitis in a German case???control cohort, BMC Dermatology, vol.8, issue.Suppl 1, p.17, 2014.
DOI : 10.1586/eci.11.100

C. Flohr and J. Mann, New insights into the epidemiology of childhood atopic dermatitis, Allergy, vol.67, issue.2 Pt 1, pp.3-16
DOI : 10.1111/all.12270

C. Pelucchi, L. Chatenoud, F. Turati, C. Galeone, L. Moja et al., Probiotics Supplementation During Pregnancy or Infancy for the Prevention of Atopic Dermatitis, Epidemiology, vol.23, issue.3, pp.402-416, 2012.
DOI : 10.1097/EDE.0b013e31824d5da2

C. Flohr and L. Yeo, Atopic Dermatitis and the Hygiene Hypothesis Revisited, Curr Probl Dermatol, vol.41, pp.1-34, 2011.
DOI : 10.1159/000323290

H. Mpairwe, E. Webb, L. Muhangi, J. Ndibazza, D. Akishule et al., Anthelminthic treatment during pregnancy is associated with increased risk of infantile eczema: randomisedcontrolled trial results. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol, pp.305-317, 2011.

P. Cooper, M. Chico, M. Vaca, A. Moncayo, J. Bland et al., Effect of albendazole treatments on the prevalence of atopy in children living in communities endemic for geohelminth parasites: a cluster-randomised trial, The Lancet, vol.367, issue.9522, pp.1598-603, 2006.
DOI : 10.1016/S0140-6736(06)68697-2

T. Tsakok, T. Mckeever, L. Yeo, and C. Flohr, Does early life exposure to antibiotics increase the risk of eczema? A systematic review, British Journal of Dermatology, vol.107, issue.Suppl. 1, pp.983-91, 2013.
DOI : 10.1111/bjd.12476

H. Kong, J. Oh, C. Deming, S. Conlan, E. Grice et al., Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis, Genome Research, vol.22, issue.5
DOI : 10.1101/gr.131029.111

K. Kisich, C. Carspecken, S. Fiéve, M. Boguniewicz, and D. Leung, Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human ??-defensin-3, Journal of Allergy and Clinical Immunology, vol.122, issue.1, pp.62-70, 2008.
DOI : 10.1016/j.jaci.2008.04.022

M. Ege, M. Mayer, N. A. Genuneit, J. Cookson, W. Braun-fahrländer et al., Exposure to Environmental Microorganisms and Childhood Asthma, New England Journal of Medicine, vol.364, issue.8, pp.701-710, 2011.
DOI : 10.1056/NEJMoa1007302

M. Ege, C. Bieli, R. Frei, R. Van-strien, J. Riedler et al., Prenatal farm exposure is related to the expression of receptors of the innate immunity and to atopic sensitization in school-age children, Journal of Allergy and Clinical Immunology, vol.117, issue.4, pp.817-840, 2006.
DOI : 10.1016/j.jaci.2005.12.1307

C. Pelucchi, C. Galeone, J. Bach, L. Vecchia, C. Chatenoud et al., Pet exposure and risk of atopic dermatitis at the pediatric age: A??meta-analysis of birth cohort studies, Journal of Allergy and Clinical Immunology, vol.132, issue.3, pp.616-638, 2013.
DOI : 10.1016/j.jaci.2013.04.009

S. Barbarot, C. Gras-leguen, H. Colas, E. Garrot, D. Darmaun et al., Lower risk of atopic dermatitis among infants born extremely preterm compared with higher gestational age, British Journal of Dermatology, vol.87, issue.Suppl. 1, pp.1257-64, 2013.
DOI : 10.1111/bjd.12581

A. Sherriff and J. Golding, Alspac Study Team Hygiene levels in a contemporary population cohort are associated with wheezing and atopic eczema in preschool infants, Arch Dis Child, 2002.

K. Thomas, T. Dean, O. Leary, C. Sach, T. Koller et al., A Randomised Controlled Trial of Ion-Exchange Water Softeners for the Treatment of Eczema in Children, PLoS Medicine, vol.327, issue.2, p.1000395, 2011.
DOI : 10.1371/journal.pmed.1000395.s002

P. Ellwood, M. Asher, L. García-marcos, H. Williams, U. Keil et al., Do fast foods cause asthma, rhinoconjunctivitis and eczema? Global findings from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three, Thorax, vol.68, issue.4, pp.351-60
DOI : 10.1136/thoraxjnl-2012-202285

G. Loss, S. Bitter, J. Wohlgensinger, R. Frei, C. Roduit et al., Prenatal and early-life exposures alter expression of innate immunity genes: The PASTURE cohort study, Journal of Allergy and Clinical Immunology, vol.130, issue.2, pp.523-553, 2012.
DOI : 10.1016/j.jaci.2012.05.049

URL : https://hal.archives-ouvertes.fr/hal-00759160

J. Silverberg, J. Hanifin, and E. Simpson, Climatic Factors Are Associated with Childhood Eczema Prevalence in the United States, Journal of Investigative Dermatology, vol.133, issue.7, pp.1752-1761
DOI : 10.1038/jid.2013.19

M. Sargen, O. Hoffstad, and D. Margolis, Warm, Humid, and High Sun Exposure Climates Are Associated with Poorly Controlled Eczema: PEER (Pediatric Eczema Elective Registry) Cohort, 2004???2012, Journal of Investigative Dermatology, vol.134, issue.1, pp.51-58, 2014.
DOI : 10.1038/jid.2013.274

B. Rehal, A. Armstrong, and A. Armstrong, Health Outcome Measures in Atopic Dermatitis: A Systematic Review of Trends in Disease Severity and Quality-of-Life Instruments 1985???2010, PLoS ONE, vol.136, issue.Suppl 48, p.17520, 2011.
DOI : 10.1371/journal.pone.0017520.t002

J. Schmitt, S. Langan, and H. Williams, European Dermato-Epidemiology Network. What are the best outcome measurements for atopic eczema? A systematic review, J Allergy Clin Immunol, 2007.

J. Hanifin, M. Thurston, M. Omoto, R. Cherill, S. Tofte et al., The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis, Experimental Dermatology, vol.44, issue.1, pp.11-19, 2001.
DOI : 10.1111/1523-1747.ep12297659

C. Charman, A. Venn, and H. Williams, The Patient-Oriented Eczema Measure, Archives of Dermatology, vol.140, issue.12, pp.1513-1522, 2004.
DOI : 10.1001/archderm.140.12.1513

J. Stalder, S. Barbarot, A. Wollenberg, E. Holm, L. De-raeve et al., Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe, Allergy, vol.27, issue.8, pp.1114-1135, 2011.
DOI : 10.1111/j.1398-9995.2011.02577.x

T. Housman, M. Patel, F. Camacho, S. Feldman, A. Fleischer et al., Use of the Self-Administered Eczema Area and Severity Index by parent caregivers: results of a validation study, British Journal of Dermatology, vol.186, issue.6
DOI : 10.1001/archderm.127.8.1239

C. Coutanceau and J. Stalder, Analysis of Correlations between Patient-Oriented SCORAD (PO-SCORAD) and Other Assessment Scores of Atopic Dermatitis Severity and Quality of Life, Dermatology, vol.229, issue.3, pp.248-55, 2014.
DOI : 10.1159/000365075

A. Taïeb, F. Boralevi, J. Seneschal, S. Merhand, V. Georgescu et al., Atopic Dermatitis Burden Scale for Adults: Development and Validation of a New Assessment Tool, Acta Dermato Venereologica, vol.95, issue.6, 2014.
DOI : 10.2340/00015555-1945

J. Chalmers, J. Schmitt, C. Apfelbacher, M. Dohil, L. Eichenfield et al., Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME), British Journal of Dermatology, vol.147, issue.Suppl. 48, pp.1318-1343, 2014.
DOI : 10.1111/bjd.13237

J. Schmitt, P. Spuls, M. Boers, K. Thomas, J. Chalmers et al., Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting, Allergy, vol.140, issue.Suppl 48, 2012.
DOI : 10.1111/j.1398-9995.2012.02874.x

A. Taïeb, Which HOME for atopic dermatitis?, British Journal of Dermatology, vol.66, issue.6, pp.1286-1293, 2014.
DOI : 10.1111/bjd.13448

H. Williams, C. Apfelbacher, J. Chalmers, J. Schmitt, E. Simpson et al., Clearing up misunderstandings around core outcomes for atopic dermatitis, British Journal of Dermatology, vol.171, issue.2, 2015.
DOI : 10.1111/bjd.13787

A. Taïeb and J. Stalder, Clearing up misunderstandings around core outcomes for atopic dermatitis: reply from the authors, British Journal of Dermatology, vol.230, issue.2, 2015.
DOI : 10.1111/bjd.13804

V. Pascoe, M. Enamandram, K. Corey, C. Cheng, E. Javorsky et al., Using the Physician Global Assessment in a Clinical Setting to Measure and Track Patient Outcomes, JAMA Dermatology, vol.151, issue.4, 2014.
DOI : 10.1001/jamadermatol.2014.3513

J. Oldhoff, U. Darsow, T. Werfel, K. Katzer, A. Wulf et al., Anti-IL-5 recombinant humanized monoclonal antibody (Mepolizumab) for the treatment of atopic dermatitis, Allergy, vol.159, issue.5, pp.693-699, 2005.
DOI : 10.1164/rccm.2304001

S. Ersser, S. Latter, A. Sibley, P. Satherley, and S. Welbourne, Psychological and educational interventions for atopic eczema in children, Cochrane Database Syst Rev, issue.3, p.4054, 2007.

H. Korting, C. Schöllmann, W. Cholcha, L. Wolff, and C. S. Group, Efficacy and tolerability of pale sulfonated shale oil cream 4% in the treatment of mild to moderate atopic eczema in children: a multicentre, randomized vehicle-controlled trial, Journal of the European Academy of Dermatology and Venereology, vol.156, issue.Suppl., pp.1176-82, 2010.
DOI : 10.1111/j.1468-3083.2010.03616.x

R. Grimalt, V. Mengeaud, and F. Cambazard, The Steroid-Sparing Effect of an Emollient Therapy in Infants with Atopic Dermatitis: A Randomized Controlled Study, Dermatology, vol.214, issue.1, pp.61-68, 2007.
DOI : 10.1159/000096915

C. Schnopp, C. Holtmann, S. Stock, R. Remling, R. Fölster-holst et al., Topical Steroids under Wet-Wrap Dressings in Atopic Dermatitis ??? A Vehicle-Controlled Trial, Dermatology, vol.204, issue.1, pp.56-65, 2002.
DOI : 10.1159/000051811

C. Hoare, W. Po, A. Williams, and H. , Systematic review of treatments for atopic eczema, Health Technol Assess Winch Engl, vol.4, issue.37, pp.1-191, 2000.

H. Williams, Established corticosteroid creams should be applied only once daily in patients with atopic eczema, BMJ, vol.334, issue.7606, p.1272, 2007.
DOI : 10.1136/bmj.39195.636319.80

J. Schmitt, L. Von-kobyletzki, A. Svensson, and C. Apfelbacher, Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials, British Journal of Dermatology, vol.249, issue.Suppl., pp.415-443, 2011.
DOI : 10.1111/j.1365-2133.2010.10030.x

M. El-batawy, M. Bosseila, H. Mashaly, and V. Hafez, Topical calcineurin inhibitors in atopic dermatitis: A systematic review and meta-analysis, Journal of Dermatological Science, vol.54, issue.2, pp.76-87, 2009.
DOI : 10.1016/j.jdermsci.2009.02.002

A. Paller, M. Lebwohl, A. Fleischer, R. Antaya, R. Langley et al., Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: Results from 3 randomized, comparative studies, Journal of the American Academy of Dermatology, vol.52, issue.5, 2005.
DOI : 10.1016/j.jaad.2004.12.038

W. Czech, M. Bräutigam, G. Weidinger, and E. Schöpf, A body-weight-independent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of life, Journal of the American Academy of Dermatology, vol.42, issue.4, pp.653-662, 2000.
DOI : 10.1016/S0190-9622(00)90180-4

J. Sowden, J. Berth-jones, J. Ross, R. Motley, R. Marks et al., Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis, The Lancet, vol.338, issue.8760, pp.137-177, 1991.
DOI : 10.1016/0140-6736(91)90134-B

T. Van-joost, F. Heule, M. Korstanje, M. Van-den-broek, H. Stenveld et al., Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study, British Journal of Dermatology, vol.129, issue.5, pp.634-674, 1994.
DOI : 10.1016/S0140-6736(89)92941-3

C. Munro, N. Levell, S. Shuster, and P. Friedmann, Maintenance treatment with cyclosporin in atopic eczema, British Journal of Dermatology, vol.122, issue.3, pp.376-80, 1994.
DOI : 10.1016/0140-6736(91)90134-B

J. Schmitt, N. Schmitt, and M. Meurer, Cyclosporin in the treatment of patients with atopic eczema ? a systematic review and meta-analysis, Journal of the European Academy of Dermatology and Venereology, vol.26, issue.0, pp.606-625, 2007.
DOI : 10.1067/mjd.2001.117010

S. Haw, M. Shin, and C. Haw, The Efficacy and Safety of Long-term Oral Cyclosporine Treatment for Patients with Atopic Dermatitis, Annals of Dermatology, vol.22, issue.1, pp.9-15, 2010.
DOI : 10.5021/ad.2010.22.1.9

J. Harper, I. Ahmed, G. Barclay, M. Lacour, P. Hoeger et al., Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy, British Journal of Dermatology, vol.338, issue.Suppl. 48, 2000.
DOI : 10.1046/j.1365-2133.2000.03241.x

H. Granlund, P. Erkko, M. Sinisalo, and S. Reitamo, Cyclosporin in atopic dermatitis: time to relapse and effect of intermittent therapy, British Journal of Dermatology, vol.324, issue.1, pp.106-118, 1995.
DOI : 10.1001/archderm.129.10.1273

N. Atakan and C. Erdem, The efficacy, tolerability and safety of a new oral formulation of Sandimmun-Sandimmun Neoral in severe refractory atopic dermatitis, J Eur Acad Dermatol Venereol JEADV, vol.11, issue.3, pp.240-246, 1998.

C. Sibbald, E. Pope, N. Ho, and M. Weinstein, Retrospective Review of Relapse after Systemic Cyclosporine in Children with Atopic Dermatitis, Pediatric Dermatology, vol.135, issue.Suppl 48, pp.36-40
DOI : 10.1111/pde.12367

C. Ryan, K. Amor, and A. Menter, The use of cyclosporine in dermatology: Part II, Journal of the American Academy of Dermatology, vol.63, issue.6, pp.949-72, 2010.
DOI : 10.1016/j.jaad.2010.02.062

S. Behnam, S. Behnam, and J. Koo, Review of cyclosporine immunosuppressive safety data in dermatology patients after two decades of use, J Drugs Dermatol JDD, vol.4, issue.2, pp.189-94, 2005.

C. Paul, V. Ho, C. Mcgeown, E. Christophers, B. Schmidtmann et al., Risk of Malignancies in Psoriasis Patients Treated with Cyclosporine: a 5 y Cohort Study, Journal of Investigative Dermatology, vol.120, issue.2, pp.211-217, 2003.
DOI : 10.1046/j.1523-1747.2003.12040.x

I. Marcil and R. Stern, Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study, The Lancet, vol.358, issue.9287, pp.1042-1047, 2001.
DOI : 10.1016/S0140-6736(01)06179-7

J. Van-der-schaft, K. Politiek, J. Van-den-reek, W. Christoffers, W. Kievit et al., Drug survival for cyclosporin A in a long-term daily practice cohort of adult patients with atopic dermatitis, Br J Dermatol Feb, vol.13, 2015.

D. Hijnen, O. Berge, . Ten, L. Timmer-de-mik, C. A. Bruijnzeel-koomen et al., Efficacy and safety of long-term treatment with cyclosporin A for atopic dermatitis, Journal of the European Academy of Dermatology and Venereology, vol.112, issue.1, pp.85-94, 2007.
DOI : 10.1111/j.1365-2133.1995.tb08633.x

F. Shaffrali, G. Colver, A. Messenger, and D. Gawkrodger, Experience with low-dose methotrexate for the treatment of eczema in the elderly, Journal of the American Academy of Dermatology, vol.48, issue.3, pp.417-426, 2003.
DOI : 10.1067/mjd.2003.137

P. Balasubramaniam and A. Ilchyshyn, Successful treatment of severe atopic dermatitis with methotrexate, Clinical and Experimental Dermatology, vol.370, issue.4, pp.436-443, 2005.
DOI : 10.1097/00002281-199905000-00012

C. Goujon, F. Bérard, K. Dahel, I. Guillot, A. Hennino et al., Methotrexate for the treatment of adult atopic dermatitis, Eur J Dermatol EJD, vol.16, issue.2, pp.155-163, 2006.

S. Weatherhead, S. Wahie, N. Reynolds, and S. Meggitt, An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema, British Journal of Dermatology, vol.16, issue.2, pp.346-51, 2007.
DOI : 10.1111/j.1365-2133.2005.06592.x

A. Lyakhovitsky, A. Barzilai, R. Heyman, S. Baum, B. Amichai et al., Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults, Journal of the European Academy of Dermatology and Venereology, vol.120, issue.6, pp.43-52, 2010.
DOI : 10.1111/j.1468-3083.2009.03351.x

M. El-khalawany, H. Hassan, D. Shaaban, N. Ghonaim, and B. Eassa, Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt, European Journal of Pediatrics, vol.135, issue.3, pp.351-357, 2013.
DOI : 10.1007/s00431-012-1893-3

C. Goujon, M. Viguier, D. Staumont, C. Bernier, M. Lahfa et al., Efficacit?? du m??thotrexate (MTX) versus ciclosporine (Cy) dans la dermatite atopique (DA) mod??r??e ?? s??v??re de l???adulte, Annales de Dermatologie et de V??n??r??ologie, vol.141, issue.12, p.302, 2014.
DOI : 10.1016/j.annder.2014.09.168

R. Stern and N. Laird, The carcinogenic risk of treatments for severe psoriasis Photochemotherapy Follow-up Study. Cancer, pp.2759-64, 1994.

R. Stern, Lymphoma Risk in Psoriasis, Archives of Dermatology, vol.142, issue.9, pp.1132-1137, 2006.
DOI : 10.1001/archderm.142.9.1132

C. Salliot and D. Van-der-heijde, Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research, Annals of the Rheumatic Diseases, vol.68, issue.7, pp.1100-1104, 2009.
DOI : 10.1136/ard.2008.093690

S. Meggitt and N. Reynolds, Azathioprine for atopic dermatitis, Clinical and Experimental Dermatology, vol.33, issue.5, pp.369-75, 2001.
DOI : 10.1046/j.1365-2133.1996.d01-1061.x

J. Berth-jones, A. Takwale, E. Tan, G. Barclay, S. Agarwal et al., Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial, British Journal of Dermatology, vol.88, issue.2, 2002.
DOI : 10.1001/archderm.131.2.193

S. Meggitt, J. Gray, and N. Reynolds, Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial, The Lancet, vol.367, issue.9513, pp.839-885, 2006.
DOI : 10.1016/S0140-6736(06)68340-2

L. Murphy and D. Atherton, A retrospective evaluation of azathioprine in severe childhood atopic eczema, using thiopurine methyltransferase levels to exclude patients at high risk of myelosuppression, British Journal of Dermatology, vol.46, issue.2, pp.308-323, 2002.
DOI : 10.1016/S0140-6736(94)92150-4

N. Fuggle, W. Bragoli, A. Mahto, M. Glover, A. Martinez et al., The adverse effect profile of oral azathioprine in pediatric atopic dermatitis, and recommendations for monitoring, Journal of the American Academy of Dermatology, vol.72, issue.1, pp.108-122
DOI : 10.1016/j.jaad.2014.08.048

M. Caufield and W. Tom, Oral azathioprine for recalcitrant pediatric atopic dermatitis: Clinical response and thiopurine monitoring, Journal of the American Academy of Dermatology, vol.68, issue.1, pp.29-35, 2013.
DOI : 10.1016/j.jaad.2012.07.001

M. Schram, E. Roekevisch, M. Leeflang, J. Bos, J. Schmitt et al., A randomized trial of methotrexate versus azathioprine for severe atopic eczema, Journal of Allergy and Clinical Immunology, vol.128, issue.2, 2011.
DOI : 10.1016/j.jaci.2011.03.024

P. Asten, J. Barrett, and D. Symmons, Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases, J Rheumatol, 1999.

C. Confavreux, P. Saddier, J. Grimaud, T. Moreau, P. Adeleine et al., Risk of cancer from azathioprine therapy in multiple sclerosis: A case-control study, Neurology, vol.46, issue.6, pp.1607-1619, 1996.
DOI : 10.1212/WNL.46.6.1607

C. Perrett, S. Walker, O. Donovan, P. Warwick, J. Harwood et al., Azathioprine treatment photosensitizes human skin to ultraviolet A radiation, British Journal of Dermatology, vol.378, issue.1, 2008.
DOI : 10.1016/j.dnarep.2006.11.003

M. Murray and J. Cohen, Mycophenolate mofetil therapy for moderate to severe atopic dermatitis, Clinical and Experimental Dermatology, vol.92, issue.0, pp.23-30, 2007.
DOI : 10.1046/j.1365-2133.2000.03623.x

I. Ballester, J. Silvestre, M. Pérez-crespo, and A. Lucas, Severe adult atopic dermatitis: treatment with mycophenolate mofetil in 8 patients]. Actas Dermo-Sifiliográficas, pp.883-890, 2009.

I. Haeck, M. Knol, O. Berge, . Ten, S. Van-velsen et al., Enteric-coated mycophenolate sodium versus cyclosporin A??as long-term treatment in adult patients with severe atopic dermatitis: A??randomized controlled trial, Journal of the American Academy of Dermatology, vol.64, issue.6, pp.1074-84, 2011.
DOI : 10.1016/j.jaad.2010.04.027

I. Jang, J. Yang, H. Lee, J. Yi, H. Kim et al., Clinical improvement and immunohistochemical findings in severe atopic dermatitis treated with interferon gamma, Journal of the American Academy of Dermatology, vol.42, issue.6, pp.1033-1073, 2000.
DOI : 10.1067/mjd.2000.104793

J. Hanifin, L. Schneider, D. Leung, C. Ellis, H. Jaffe et al., Recombinant interferon gamma therapy for atopic dermatitis, Journal of the American Academy of Dermatology, vol.28, issue.2, pp.189-97, 1993.
DOI : 10.1016/0190-9622(93)70026-P

T. Keaney, T. Bhutani, P. Sivanesan, G. Bandow, S. Weinstein et al., Open-label, pilot study examining sequential therapy with oral tacrolimus and topical tacrolimus for severe atopic dermatitis, Journal of the American Academy of Dermatology, vol.67, issue.4, pp.636-677, 2012.
DOI : 10.1016/j.jaad.2011.10.033

F. Lee, B. Frankum, and C. Katelaris, Poor efficacy of oral tacrolimus in the treatment of severe generalized atopic eczema in adults: A small retrospective case series, Australasian Journal of Dermatology, vol.25, issue.1, pp.295-302, 2012.
DOI : 10.1111/j.1440-0960.2011.00789.x

J. Schmitt, K. Schäkel, R. Fölster-holst, A. Bauer, R. Oertel et al., Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicentre trial, British Journal of Dermatology, vol.143, issue.Suppl. 62, pp.661-669, 2010.
DOI : 10.1111/j.1365-2133.2009.09561.x

F. Garritsen, E. Roekevisch, J. Van-der-schaft, J. Deinum, P. Spuls et al., Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres, Journal of the European Academy of Dermatology and Venereology, vol.169, issue.10, 2009.
DOI : 10.1111/jdv.13064

T. Rath and A. Rubbert, Drug combinations with methotrexate to treat rheumatoid arthritis, Clin Exp Rheumatol, vol.28, issue.5, pp.52-59, 2010.

A. Taïeb, J. Seneschal, and M. Mossalayi, Biologics in atopic dermatitis, JDDG: Journal der Deutschen Dermatologischen Gesellschaft, vol.64, issue.7, pp.174-182, 2012.
DOI : 10.1111/j.1610-0387.2011.07760.x

B. Belloni, M. Ziai, A. Lim, B. Lemercier, M. Sbornik et al., Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels, Journal of Allergy and Clinical Immunology, vol.120, issue.5, pp.1223-1228, 2007.
DOI : 10.1016/j.jaci.2007.08.060

. Fernández-antón, M. Martínez, V. Leis-dosil, F. Alfageme-roldán, A. Paravisini et al., Omalizumab for the treatment of atopic dermatitis. Actas Dermo- Sifiliográficas, pp.624-632, 2012.

P. Heil, D. Maurer, B. Klein, T. Hultsch, and G. Stingl, Omalizumab therapy in atopic dermatitis: depletion of IgE does not improve the clinical course - a randomized, placebo-controlled and double blind pilot study, JDDG: Journal der Deutschen Dermatologischen Gesellschaft, vol.131, issue.12, pp.990-998, 2010.
DOI : 10.1111/j.1610-0387.2010.07497.x

R. Krathen and S. Hsu, Failure of omalizumab for treatment of severe adult atopic dermatitis, Journal of the American Academy of Dermatology, vol.53, issue.2, pp.338-378, 2005.
DOI : 10.1016/j.jaad.2005.02.014

D. Simon, J. Wittwer, G. Kostylina, U. Buettiker, H. Simon et al., Alefacept (lymphocyte function-associated molecule 3/IgG fusion protein) treatment for atopic eczema, Journal of Allergy and Clinical Immunology, vol.122, issue.2, pp.423-427, 2008.
DOI : 10.1016/j.jaci.2008.06.010

D. Moul, S. Routhouska, M. Robinson, and N. Korman, Alefacept for moderate to severe atopic dermatitis: A pilot study in adults, Journal of the American Academy of Dermatology, vol.58, issue.6, pp.984-993, 2008.
DOI : 10.1016/j.jaad.2008.02.007

A. Jacobi, C. Antoni, B. Manger, G. Schuler, and M. Hertl, Infliximab in the treatment of moderate to severe atopic dermatitis, Journal of the American Academy of Dermatology, vol.52, issue.3, pp.522-528, 2005.
DOI : 10.1016/j.jaad.2004.11.022

D. Simon, S. Hösli, G. Kostylina, N. Yawalkar, and H. Simon, Anti-CD20 (rituximab) treatment improves atopic eczema, Journal of Allergy and Clinical Immunology, vol.121, issue.1, pp.122-130, 2008.
DOI : 10.1016/j.jaci.2007.11.016

A. Otsuka, H. Doi, G. Egawa, A. Maekawa, T. Fujita et al., Possible new therapeutic strategy to regulate atopic dermatitis through upregulating filaggrin expression, Journal of Allergy and Clinical Immunology, vol.133, issue.1, pp.139-185, 2014.
DOI : 10.1016/j.jaci.2013.07.027

T. Stout, T. Mcfarland, J. Mitchell, B. Appukuttan, and J. Stout, Recombinant Filaggrin Is Internalized and Processed to Correct Filaggrin Deficiency, Journal of Investigative Dermatology, vol.134, issue.2, 2014.
DOI : 10.1038/jid.2013.284